Lisata TherapeuticsLSTA

13F holders, Q3 2024 (September 30)
20holders −2
1new positions
3sold out
1famous investor
$3.00avg. 13F price*

At the end of Q3 2024, 20 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 3 sold out. The largest holders were BML Capital Management, LLC ($854K), Vanguard Group Inc. ($559K) and Renaissance Technologies ($311K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Lisata Therapeutics Inc.
CUSIP
128058302
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 21Q1 2024Q2 2024: 22Q2 2024Q3 2024: 20Q3 2024Q4 2024: 21Q4 2024Q1 2025: 22Q1 2025Q2 2025: 20Q2 2025Q3 2025: 21Q3 2025Q4 2025: 25Q4 2025Q1 2026: 34Q1 2026Q2 2026: 31Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$33K
Exits3$8K

All 13F filers, Q2 2024 → Q3 2024: 20,930 shares bought and 7,113 shares sold, net +13,817 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

BML Capital Management, LLC 0.50% No change 284,669 $854K
Vanguard Group Inc. 0.00% Add +1.1% 186,366 $559K
Renaissance Technologies 0.00% Add +2.0% 103,622 $311K
BlackRock, Inc. 0.00% — 56,013 $168K
Geode Capital Management, LLC 0.00% Add +9.4% 55,681 $167K
Dimensional Fund Advisors LP 0.00% Add +0.0% 17,340 $52K
State Street Corp. 0.00% No change 14,348 $43K
Cook Wealth, LLC 0.02% No change 12,175 $34K
Susquehanna International Group, LLP 0.00% New 11,019 $33K
HighTower Advisors, LLC 0.00% Reduce -0.0% 10,042 $30K
Bank of America Corp. 0.00% Add +0.0% 9,715 $29K
Founders Capital Management 0.00% No change 2,000 $6K
Tower Research Capital LLC (TRC) 0.00% Add +246.8% 1,526 $5K
Morgan Stanley 0.00% Reduce -42.5% 1,466 $4K
UBS Group AG 0.00% Reduce -96.6% 125 $375
JPMorgan Chase & Co. 0.00% Reduce -6.3% 15 $45
Barclays PLC 0.00% Add +75.0% 7 $21
Wells Fargo & Company 0.00% No change 1 $3
Osaic Holdings, Inc. 0.00% No change 1 $3
Royal Bank of Canada 0.00% No change 52 $0

"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.